Unbound MEDLINE

Dantrolene: Mechanisms of Neuroprotection and Possible Clinical Applications in the Neurointensive Care Unit. Neurocritical care [Neurocrit Care] Journal article

 
TitleDantrolene: Mechanisms of Neuroprotection and Possible Clinical Applications in the Neurointensive Care Unit.
Author(s)Muehlschlegel S, Sims JR 
InstitutionDepartments of Neurology, Anesthesiology/Critical Care and Surgery, UMASS Memorial Medical Center, University Campus, University of Massachusetts Medical School, Worcester, MA, 01605, USA.
SourceNeurocrit Care 2008 Aug 12.
AbstractCalcium plays a central role in neuronal function and injury. Dantrolene, an inhibitor of the ryanodine receptor, inhibits intracellular calcium release from the sarco-endoplasmic reticulum. We review the available data of dantrolene as a potential neuroprotective agent and briefly summarize its other pharmacologic effects that may have potential applications for patients in the neurointensive care unit (NICU). Areas with the need for continued research are identified.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID18696266
  
Advertise on this site.